186 related articles for article (PubMed ID: 24223154)
1. ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study.
Tomlinson LA; Abel GA; Chaudhry AN; Tomson CR; Wilkinson IB; Roland MO; Payne RA
PLoS One; 2013; 8(11):e78465. PubMed ID: 24223154
[TBL] [Abstract][Full Text] [Related]
2. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
[TBL] [Abstract][Full Text] [Related]
3. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
[TBL] [Abstract][Full Text] [Related]
4. Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Type 1 Cardiorenal Syndrome.
Ilges DT; Dermody ML; Blankenship C; Mansfield V; Van Tuyl JS
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):611-618. PubMed ID: 34138673
[TBL] [Abstract][Full Text] [Related]
5. Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study.
Hines A; Li X; Ortiz-Soriano V; Saleh S; Litteral J; Ruiz-Conejo M; Wald R; Silver SA; Neyra JA
Am J Nephrol; 2020; 51(4):266-275. PubMed ID: 32088714
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study.
Slagelse C; Gammelager H; Iversen LH; Liu KD; Sørensen HTT; Christiansen CF
BMJ Open; 2019 Nov; 9(11):e032964. PubMed ID: 31753901
[TBL] [Abstract][Full Text] [Related]
7. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
[TBL] [Abstract][Full Text] [Related]
8. Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life.
Hirano D; Miwa S; Kakegawa D; Umeda C; Takemasa Y; Tokunaga A; Yuhei K; Ito A
Pediatr Nephrol; 2021 Jul; 36(7):1907-1914. PubMed ID: 33462699
[TBL] [Abstract][Full Text] [Related]
9. Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.
Kitchlu A; McArthur E; Amir E; Booth CM; Sutradhar R; Majeed H; Nash DM; Silver SA; Garg AX; Chan CT; Kim SJ; Wald R
J Natl Cancer Inst; 2019 Jul; 111(7):727-736. PubMed ID: 30423160
[TBL] [Abstract][Full Text] [Related]
10. The Concomitant Use of Diuretics, Non-Steroidal Anti-Inflammatory Drugs, and Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers (Triple Whammy), Extreme Heat, and In-Hospital Acute Kidney Injury in Older Medical Patients.
Mangoni AA; Kholmurodova F; Mayner L; Hakendorf P; Woodman RJ
Adv Ther; 2017 Nov; 34(11):2534-2541. PubMed ID: 29116624
[TBL] [Abstract][Full Text] [Related]
11. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations.
Parikh RV; Nash DM; Brimble KS; Markle-Reid M; Tan TC; McArthur E; Khoshniat-Rad F; Sood MM; Zheng S; Pravoverov L; Nesrallah GE; Garg AX; Go AS
Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006415. PubMed ID: 32873054
[TBL] [Abstract][Full Text] [Related]
12. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure.
Kalra PA; Kumwenda M; MacDowall P; Roland MO
BMJ; 1999 Jan; 318(7178):234-7. PubMed ID: 9915733
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy.
Shih CJ; Chen HT; Kuo SC; Li SY; Lai PH; Chen SC; Ou SM; Chen YT
CMAJ; 2016 May; 188(8):E148-E157. PubMed ID: 27001739
[TBL] [Abstract][Full Text] [Related]
14. Estimating the risk of acute kidney injury associated with use of diuretics and renin angiotensin aldosterone system inhibitors: A population based cohort study using the clinical practice research datalink.
Scott J; Jones T; Redaniel MT; May MT; Ben-Shlomo Y; Caskey F
BMC Nephrol; 2019 Dec; 20(1):481. PubMed ID: 31888533
[TBL] [Abstract][Full Text] [Related]
15. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.
Dreischulte T; Morales DR; Bell S; Guthrie B
Kidney Int; 2015 Aug; 88(2):396-403. PubMed ID: 25874600
[TBL] [Abstract][Full Text] [Related]
16. Prescribing and emergency admissions for heart failure in greater Glasgow.
Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
[TBL] [Abstract][Full Text] [Related]
17. Study of Acute Kidney Injury on 309 Hypertensive Inpatients with ACEI/ARB - Diuretic Treatment.
Chen Q; Zhu S; Liao J; He W
J Natl Med Assoc; 2018 Jun; 110(3):287-296. PubMed ID: 29778133
[TBL] [Abstract][Full Text] [Related]
18. Contrast-associated AKI and use of cardiovascular medications after acute coronary syndrome.
Leung KC; Pannu N; Tan Z; Ghali WA; Knudtson ML; Hemmelgarn BR; Tonelli M; James MT;
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1840-8. PubMed ID: 25318754
[TBL] [Abstract][Full Text] [Related]
19. Safer Prescribing--A Trial of Education, Informatics, and Financial Incentives.
Dreischulte T; Donnan P; Grant A; Hapca A; McCowan C; Guthrie B
N Engl J Med; 2016 Mar; 374(11):1053-64. PubMed ID: 26981935
[TBL] [Abstract][Full Text] [Related]
20. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
